Abstract: The present invention generally relates to a wet wipe or sheet that is suitable for contacting the skin and removing mucus from the skin. More specifically, the present invention relates to a wet wipe having an aqueous saline component suitable for dissolving and removing mucus in combination with the fabric matrix of the wet wipe. Typically, the fabric matrix of the wet wipe has a capacity of about 125 grams of solution per square meter, and it is impregnated with the aqueous saline solution to a level at or below approximately 80% of the absorbent capacity of the matrix.

Abstract: The present invention is directed to the use of an agent selected from ethyl alcohol, isopropyl alcohol or a mixture thereof and a topically acceptable polymeric carrier in the preparation of a composition for the treatment of burns.

Abstract: The present invention features compositions comprising at least one compound of the formula I or formula II: wherein R1, R2, R3, R4, and R5 independently, are selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C6 hydroxyalkyl, or a cosmetically acceptable salt thereof, and the use thereof.

Abstract: The present invention relates to a composition comprising panthenol, a collagen synthesis stimulating peptide and an anti-inflammatory extract. The compositions are particular useful for preventing and treating stretch marks.

Abstract: A method of making a low molecular weight fraction of Phyllanthus niruri is provided. Such low molecular weight fraction is particularly useful for treating the skin, for example skin in need of treatment for signs of aging, for reducing inflammation, or for skin lightening.

Abstract: The present invention relates to a composition comprising an NF?B-inhibitor and a tropoelastin promoter, and methods of treating signs of skin aging using said compositions.

Abstract: The present invention relates to a composition comprising an NF?B-inhibitor and a non-retinoid collagen promoter.

Abstract: A composition for oral administration containing capsaicinoids associated with a formulation base acceptable for oral administration, the formulation base comprising an oil and an additive solid or pasty at room temperature which represents 5 to 20 wt. %, preferably 8 to 15 wt. % of the composition.

Abstract: The present invention is related to a method for treating epiphora, the method comprising administering to a nasal area of a subject in need thereof a composition comprising camphor, eucalyptus oil, and menthol, wherein the composition is substantially free of lipids other than the eucalyptus oil.

Abstract: A natural pharmaceutical preparation for treating hypoproteinemia, includes at least one member selected from the group consisting of a drug of increasing human serum albium, a drug of improving and enhance immunity, a drug of treating hepatitis B, a drug of treating Hepatitis C, a drug of treating acquired immune deficiency syndrome (AIDS), a drug of treating Tuberculosis, a drug of treat Fibrosis, a drug of treating hydrothorax, a drug of easing pain, a drug of stopping diarrhea, a drug of arresting coughing, a drug of reducing inflammation, and a drug of increasing urine.

Abstract: The invention concerns a natural vegetable oil selected among palm oil, corn germ oil, sunflower oil and canola oil, concentrated in unsaponifiable matters, such that said oil unsaponifiable matter content is 3 to 15% m/m. Said concentrated natural vegetable oil constitutes a novel food ingredient enriched in particular in vitamin E and phytosterol, useful as favored food source in vitamin E and phytosterol, meeting recommended daily intake.

Abstract: A method for preparing a milk thistle fruit extract, in particular a flavanolignan preparation, has an increased release rate and improved absorbability. A pharmaceutical preparation contains the extract and is used, in particular for the treatment and prevention of liver diseases.

Abstract: A cosmetic or pharmaceutical composition, to be applied topically is described, which has a hydrophilic outer phase, at least one cosmetic and/or pharmaceutical active ingredient and at least one carrier substance for the active ingredient. The carrier substance here forms such structures, which comprises at least two lamellar double membrane layers arranged one over another in the manner of a sandwich, wherein between adjacent double membrane layers, aligned parallel to each other, a layer of an inner phase is respectively arranged.

Abstract: The provision of a GM-CSF increasing agent or a TNF-? modulator, which is a composition comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; or a health food, nutritional supplementary food, or the like for increase of GM-CSF, and the prevention of Crohn's disease and the like, and the prognosis thereof, which comprises Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica.

Abstract: The present invention provides a novel method for treating oral conditions and upper gastrointestinal conditions in a subject by providing an inventive oral dosage form of a pharmaceutical composition comprising an effective amount of at least one antifungal and optionally a flavor modifier and/or salivation component such as an herbal component. In the present invention, the subjects have either not been diagnosed or do not have active or recurrent fungal infections. Specifically, the present invention is directed to chewable dosage forms.

Abstract: The present invention relates to a glucan derived from yeast having a beta-(1, 3)-backbone with one or more beta-(1, 3)-side chains linked thereto for use in the treatment or prevention of inflammatory bowel disease and related diseases of abnormal bowel function in an animal, in particular to such uses employing a soluble glucan, e.g. from Saccharomyces cerevisiae, preferably when administered orally. The invention also relates to alternative treatments of inflammatory bowel disease and related diseases of abnormal bowel function utilising meal or protein derived from Asteraceae.

Abstract: The invention provides a composition and a method for lowering blood serum cholesterol levels or for preventing elevated blood serum cholesterol levels, as well as a suitable composition comprising (a) one or more phytosterols and/or phytostanols capable of reducing cholesterol absorption in the intestine and/or one or more soluble fibres capable of inhibiting ileal bile acid absorption, (b) a composition capable of inhibiting cholesterol biosynthesis, and (c) a composition capable of increasing cholesterol metabolism, wherein at least one of compositions (b) and (c) is preferably derived from plants.

Abstract: The present invention relates to plant sprout-based stable oil-in-water emulsions wherein the monacyl- and diacylglycerol content is at least 20% by weight, the free fatty acid content is not more than 10% by weight and comprise an aqueous homogenate of sprouted oily seeds of which the own enzymes and emulsifying substances are capable to form the emulsion. Furthermore, the invention also relates to the preparation of said emulsions as well as to various applications thereof.

Abstract: A food supplement, either in the form of a snack bar or a beverage, which contains one or more cartilage enhancing supplements is provided. The cartilage supplements include chondroitin, glucosamine, and hyaluronic acid. The food supplement may additionally be fortified with cetyl myristoleate. The beverage is a mixture of a juice drink base which may include a water-based fruit flavored juice prepared using a pasteurization process at a relatively high temperature and a cartilage supplement solution which includes a cartilage supplement prepared at a relatively low temperature. The beverage may be carbonated, non-carbonated or concentrated. The preferred cartilage supplement is glucosamine, preferably associated with a counter ion, more preferably as glucosamine HCl. The supplement also contains vitamin C (ascorbic acid) and calcium hydroxide powder.

Abstract: An ointment made of sunflower oil and yellow candle (paraffin); the candles are dissolved in the heated sunflower oil container; the yellow candle and sunflower oil mixture turns into a cream which then the ointment is formed, while hot the ointment is pasted on a clean cloth by dipping the cloth into the heated cream mixture; the pasted cloth is kept chilled in the freezer until is ready to be applied; the ointment is applied chilled by applying the pasted cloth into the bum wound and is left on for 10 hours or less, after 10 hours the pasted cloth is replaced with another pasted cloth and the procedure is repeated until the ointment heals the wound, the chilled ointment immediately cools the bum wound and keeps it cool, removes the pain, heals the wound, does not leave wrinkles in the skin

Abstract: A polyphenol-rich plant extract is used in combination with at least one hydrating or humectant agent, as cosmetic active agents in a cosmetic composition. The combination improves hydrating and antioxidant cosmetic care.

Abstract: The present invention refers to pharmaceutical formulations based on lipids for ophthalmic use comprising a phospholipid component composed of zwitterionic phospholipids of natural origin and an oily component composed of oils of natural origin emulsified in water. In particular, the invention refers to ophthalmic formulations useful, for example, for transporting drugs to the eye and in the treatment of ocular dryness, capable of restoring the lipid layer of the tear film. In particular, in a non-transitory but pathological situation such as the dry eye syndrome, such formulations also succeed in reducing the often-present inflammatory component.

Abstract: Disclosed are substrates suited for dispensing air treatment chemicals upon being heated. Granular particles, preferably sand with a phenolic binder, are adhered together to form a substrate body having a network of pores. A volatile air treatment chemical is disposed in the pores. The particle size and pores are such that the smaller particles of the substrate are grouped at one end, preferably an end adjacent to a projecting nose. This structure tends to wick the volatile air treatment chemical towards the nose, and heating that area can lead to efficient, and rechargeable, dispensing. Methods for using such substrates, and methods for forming such substrates, are disclosed.

Abstract: The horse liniment is a veterinary composition for topical application for the relief of muscle and joint pain in horses. The composition contains, by weight, about 49% alcohol, 20% olive oil, 10% arnica, 14% creosote, 1% iodine, 2% turpentine, 2% camphor, and 2% alum. The ingredients may be mixed at room temperature, the powdered ingredients being soluble in the alcohol-olive oil base. The composition is applied topically to the affected muscles or joints in conventional manner as needed. The composition has been found to be effective, often with a single application, with increased range of motion, an absence or reduction of limping, increased energy, and other signs of a healthy, active horse.

Abstract: Disclosed is a dry composition prepared from red grape by natural fermentation that is, once brewed, steeped within hot water, tasteful to ingest as herb tea, and that complementary contains antioxidants, Catechin, Resveratrol, Tannin, Quercetin bearing anti-inflammatory and blood glucose lowering capacities; as well as a human skin rejuvenating natural product derived there from.

Abstract: Disclosed are therapeutic hydrogels for atopic dermatitis and a method for preparing the same. The hydrogels comprises a biocompatible polymer, a polyalcohol, and a medicinal plant extract. The hydrogels can carry medicinally effective ingredients for a sustained period of time and absorb wound exudates properly. The hydrogels have suitable gel strength and, when applied to a wound, can prevent bacterial infection of the wound. Moreover, the methods employing radiation allow the polymer chains to be crosslinked to each other, and also bring about a sterilization effect in the final hydrogel. There are no problems of toxic residues in the hydrogels. They are easy to attach to the skin and concomitantly provide a cool feeling. Supported by the laminate of hydrophilic non-woven fabric sheet and polyethylene film, the hydrogel retain water for a prolonged period of time and thus are useful in the treatment of contact dermatitis and atopic dermatitis.

Abstract: The present invention relates to a water insoluble helychrisum extract, a process for preparing the same and its use for preparing pharmaceutical compositions for oral and/or topical administration. Furthermore, the present invention relates to the pharmaceutical compositions including said extract.

Abstract: A method for treating H5N1 avian influenza caused by H5N1 avian influenza virus in an animal by administering to an animal suffering from H5N1 avian influenza, a pharmaceutical composition of Solidago virgaurea. The pharmaceutical composition of Solidago virgaurea comprises an herbal stock solution extracted from the natural plant Solidago virgaurea. The herbal extract has anti-H5N1 avian influenza and anti-influenza properties. The pharmaceutical composition of Solidago virgaurea may further contain excipients, adjuvants or carriers.

Abstract: The invention relates to methods and compositions for treating skin aging, said compositions comprising at least one tropoelastin promoter and at least one tropoelastin crosslinker.

Abstract: A semi-flexible insecticide strip is removably attached to the belt of a pelt collar to regenerate a pest-killing medicament and increase its efficacy. The strip is secured to the belt surface that faces the animal skin or fur by attachment loops or edged retainers that are generally perpendicular to the length direction of the belt. Due to the geometry and elasticity of the semi-flexible insecticide strip, and its attachment method, the strip contacts the skin or fur of the animal despite movement of the pet collar when the animal is being exercised with a pet leash attached thereto. The contact effectively transfers the insecticide and kills ticks and fleas or retards development of mature flea adults. The insecticide is contained within a plurality of plastic pores of the insecticide strip or in a sponge affixed thereto.

Abstract: There are provided various compounds and compositions comprising polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds and compositions can be useful as cancer chemopreventive agents. They can also be useful for enhancing solubility of various active agents and enhancing their bioavailability.

Abstract: The present invention features compositions comprising at least one compound of the formula I or formula II: wherein R1, R2, R3, R4, and R5 independently, are selected from the group consisting of hydrogen, C1-C6 alkyl, C1-C6 hydroxyalkyl, or a cosmetically acceptable salt thereof, and the use thereof.

Abstract: A propellant-free foamable transparent composition, foamable by mixing with air or by hand rubbing, comprises a water-immiscible oil composition comprising at least one water-immiscible oil, which may be a mineral oil or vegetable oil, a siloxane resin foam stabiliser which is miscible in the water-immiscible oil composition to form a transparent liquid, and potentially a siloxane resin solubilising agent. The composition may be used for cosmetic applications.

Abstract: The present invention relates to a hydrogel of chitosan carboxyalkylamide, characterised in that it has a pH value close to that of the skin, comprised between 6.5 and 7.2, and in that the chitosan carboxy-alkylamide is constituted by 40 to 90 mole % of D-glucosamine N-carboxyalkylamide units of formula (I) where n represents an integer ranging from 1 to 8, from 60 to 10 mole % of protonated D-glucosamine units, and from 5 to 15 mole % of N-acetyl-D-glucosamine units. The present invention also relates to a dehydration product of such a gel and the cosmetic and/or dermatological utilisation of the gel and the dehydration product.

Abstract: The absorption and deposition of carotenoids added to poultry diets into the yolk of eggs produced by the poultry is improved by adding a carotenoid formulation comprising a carotenoid, a vegetable oil, a surfactant, a chelating agent, an antioxidant, an alkali and a solvent. The carotenoid formulation can reduce the crystalline nature of lutein for its better dissolution in the formulation and the diet. This new formulation is capable of making more micelles for an effective transfer of lutein from the formulations to the aqueous layer. The new formulation can increase the bioavailability of lutein in chicken biological system and leads to more deposition in the blood and the egg. The lutein deposition in the egg was consistent for an extended period of time when this new formulation was added to the diet. Addition of this carotenoid formulation to the diet increased the antioxidant power of the blood. Eggs produced by poultry fed diets supplemented by the formulation have in excess of 0.

Abstract: A composition comprising an aqueous extract of camomile flowers is useful for the treatment of a proliferative and/or inflammatory condition.

Abstract: Compositions and methods are disclosed for use in the treatment or prevention of hair loss and/or the promotion of hair growth. The compositions comprise in combination Centella asiatica extract, or one or more active principles thereof, green coffee extract, or one or more active principles thereof, and one or more antioxidants, and a dermatologically acceptable carrier.

Abstract: An O/W emulsion which comprises one or more fatty alcohols, one or more glycerol esters of fatty acids and at least 15% by weight, based on the total weight of the emulsion, of at least one moisturizer. Also disclosed is a cosmetic composition which comprises the emulsion.

Abstract: The present invention relates to a cosmetic composition, which comprises a combination of at least two osmolytes chosen from the group comprising taurine or a derivative thereof, inositol, betaine and trehalose. This composition is intended for restoring, maintaining or reinforcing the moisturization of the skin and/or for protecting it against different types of stress and/or for preventing or retarding the appearance of the signs of aging of the skin, or for attenuating the effects thereof, or alternatively for promoting cell or tissue longevity.

Abstract: An anhydrous multiphase gel system consisting of an outer lipid matrix and an inner phase gelled by means of a polymer is described, which can be obtained by a) Melting the lipid phase with the formation of a liquid lipid phase, b) Mixing and homogenizing polymers or polymer blends capable of swelling with the formation of a polymer phase to be dispersed, c) Combining the polymer phase with the liquid lipid phase and homogenizing the phases, and d) Cold stirring the phase mixture until a solid gel-like mixed structure of the entire system is formed. The anhydrous multiphase gel system is particularly suitable for taking up difficultly soluble active substances in high concentration and for providing topical and transdermal applications. The described system is called an EDRS, “Entrapped Drug Reservoir System”.

Abstract: The invention provides a therapeutic composition, simultaneously containing (1) at least one polar solvent, selected from the group of a short-chain mono-alcohol and a diol; (2) between about 2% and about 25% of at least two keratolytic agents; and (3) a therapeutically safe and effective concentration of a antifungal agent It further provides a kit, consisting of an occlusive device and a therapeutic composition, useful for treatment of fungal skin infection.

Abstract: A stick lip balm with efficacious amounts of natural moisturizer and organoleptic/sensory attributes of lip feel associated with moisturizers and emollients is provided. The lip balm of the invention comprises at least 90% botanically derived materials and can be formed into a stick sufficiently robust to substantially retain the stick shape under normal conditions of shipping, storage and usage. A method of making the stick lip balm is also provided.

Abstract: This invention describes a comprehensive nutraceutical designed to antagonize major mitigating factors to the degenerative process associated with Parkinson's disease. The formulation is comprised of a primary base of pyruvate, succinate, ?-Ketoglutarate and/or oxaloacetate, niacin/NADH, fruit extracts, anthocyanins, further combined with specific macro/micronutrients, trace elements, amino acids, flavonoids and concentrated plant sources. The nutraceutical contains all natural substances that should mitigate many of the neurodegenerative processes known to be associated with PD. Mechanisms addressed are to prevent the loss of ATP/by 1-methyl-4-phenylpyridinium rotenone, scavenge hydrogen peroxide/O2.

Abstract: An object made of at least two layers is disclosed, in which a first layer is a biologically degradable water-soluble support material containing an active agent and connected to at least one second layer, which is made up of a biologically degradable but water-insoluble material in the form of fibers. The active agents can be pharmaceutical agents, cosmetics, cleaning agents, agrochemicals and biocides. The object serves for the controlled release of at least one active agent based on the effect of water. The fiber structure of the second layer permits a control of the speed of water entry and/or exit.

Abstract: Extracts of members of the plant family Asclepiadaceae can alter or diminish a person's ability to taste some sugars. As such, the extracts can be used help a person reduce their caloric intake and thereby reduce their body weight or body fat percentage. An extract of the plant Gymnema sylvestre can be used as an ingredient in a lip balm. The Gymnema-containing lip balm can be applied to a person's lips before they eat a sugar-containing food item. The lip balm can also contain other weight-loss promoting substances such as jasmine, grapefruit, vanilla, lemon, peppermint, oregano, ylang ylang, and combinations of the preceding substances.

Abstract: The present invention provides novel compositions comprising a Nigella sativa L. polyunsaturated fatty acid fraction. The present invention also provides novel compositions, particularly topical compositions, comprising octadecadienoic acid and/or octadecenoic acid. The present invention provides novel methods for treating and preventing fungal infections, bacterial infections, skin conditions, anal fissures, hemorrhoids, inflammation, pain, allergic reactions, and septic wounds by administering, preferably topically administering, an effective amount of a composition comprising octadecadienoic acid and/or octadecenoic acid, or a composition comprising the Nigella sativa L. polyunsaturated fatty acid fraction.

Abstract: The present invention is directed to a composition for the treatment of the hair roots in order to prevent or at least to reduce the loss of hairs, to restore the growth of the hairs and to prevent or at least to reduce the formation of white hairs. This composition contains an extract of at least one Chamomilla plant and/or of at least one Achillea plant.

Abstract: A liquid analgesic composition and method for its preparation and use. The composition may be prepared using plant extracts obtained by solar infusion. The composition may include extracts from dandelion, arnica, and chamomile, as well as other essential oils.

Abstract: The invention is directed to a method for treating topical burns with compositions comprising a silicone containing compound, a Vitamin E compound and a local anesthetic.

Abstract: The invention relates to a new derivative of aryldimethylpyrazolone of formula (I) which is effective in reducing unsightly cellulite, and compositions containing it.